We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1.06B
AUM Growth
-$4.21M
Cap. Flow
-$36.2M
Cap. Flow %
-3.4%
Top 10 Hldgs %
45.51%
Holding
2,874
New
227
Increased
1,384
Reduced
630
Closed
115

Top Sells

Rank Stock Value
1
OCSL icon
Oaktree Specialty Lending
OCSL
+$12.7M
2
NVDA icon
NVIDIA
NVDA
+$6.29M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.66M
4
AAPL icon
Apple
AAPL
+$3.19M
5
AVGO icon
Broadcom
AVGO
+$2.17M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 12.25%
3 Healthcare 6.29%
4 Communication Services 4.39%
5 Consumer Discretionary 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHIN icon
1926
Phinia Inc
PHIN
$2.7B
$5.79K ﹤0.01%
147
PLXS icon
1927
Plexus
PLXS
$7.13B
$5.78K ﹤0.01%
56
+32
+133% +$3.29K
ESE icon
1928
ESCO Technologies
ESE
$7.79B
$5.78K ﹤0.01%
55
+31
+129% +$3.27K
RLI icon
1929
RLI Corp
RLI
$5.83B
$5.77K ﹤0.01%
82
-48
-37% -$3.44K
ASH icon
1930
Ashland
ASH
$3.45B
$5.76K ﹤0.01%
61
+8
+15% +$777
VC icon
1931
Visteon
VC
$2.8B
$5.76K ﹤0.01%
54
-95
-64% -$10.5K
NSIT icon
1932
Insight Enterprises
NSIT
$4.54B
$5.75K ﹤0.01%
29
XLB icon
1933
State Street Materials Select Sector SPDR ETF
XLB
$8.71B
$5.74K ﹤0.01%
130
CLDX icon
1934
Celldex Therapeutics
CLDX
$3.37B
$5.74K ﹤0.01%
155
CVSA
1935
Covista Inc
CVSA
$4.38B
$5.73K ﹤0.01%
84
BIPC icon
1936
Brookfield Infrastructure
BIPC
$4.71B
$5.72K ﹤0.01%
170
-40
-19% -$1.33K
CRI icon
1937
Carter's
CRI
$1.48B
$5.7K ﹤0.01%
92
+57
+163% +$3.96K
WSC icon
1938
WillScot Mobile Mini Holdings
WSC
$4.18B
$5.68K ﹤0.01%
151
+7
+5% +$277
TK icon
1939
Teekay
TK
$973M
$5.68K ﹤0.01%
633
VERV
1940
DELISTED
Verve Therapeutics
VERV
$5.67K ﹤0.01%
1,163
+852
+274% +$5.36K
UEC icon
1941
Uranium Energy
UEC
$5.63B
$5.67K ﹤0.01%
944
+159
+20% +$1.08K
NSSC icon
1942
Napco Security Technologies
NSSC
$1.43B
$5.66K ﹤0.01%
109
SBOW
1943
DELISTED
SilverBow Resources, Inc.
SBOW
$5.64K ﹤0.01%
149
+133
+831% +$4.67K
DUOL icon
1944
Duolingo
DUOL
$6.42B
$5.63K ﹤0.01%
27
+5
+23% +$1.02K
RDFN
1945
DELISTED
Redfin
RDFN
$5.61K ﹤0.01%
934
+202
+28% +$1.26K
JRVR icon
1946
James River Group Holdings
JRVR
$210M
$5.6K ﹤0.01%
725
+220
+44% +$1.81K
ITOS
1947
DELISTED
iTeos Therapeutics
ITOS
$5.58K ﹤0.01%
376
+94
+33% +$1.35K
STAG icon
1948
STAG Industrial
STAG
$7.09B
$5.55K ﹤0.01%
154
NVRO
1949
DELISTED
NEVRO CORP.
NVRO
$5.54K ﹤0.01%
658
+632
+2,431% +$6.74K
VIRT icon
1950
Virtu Financial
VIRT
$4.92B
$5.52K ﹤0.01%
246
+204
+486% +$4.55K

Similar funds

Lindbrook Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Lindbrook Capital held 2,874 positions worth $1.06B, down 0.39% from $1.07B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital withdrew a net $36.2M in Q2 2024, closing 115 positions and reducing 630 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $1.24M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lindbrook Capital opened a new position in Nuveen ESG Small-Cap ETF worth $323K.

  • Lindbrook Capital's largest Q2 2024 buy was Nuveen ESG Small-Cap ETF: 8,216 shares worth $323K.
  • Lindbrook Capital added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $3.36M increase.
  • Lindbrook Capital's biggest Q2 2024 reduction was Oaktree Specialty Lending, cutting an estimated $12.7M.
  • Lindbrook Capital fully exited ProShares UltraPro QQQ in Q2 2024, selling an estimated $1.24M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $1.06B portfolio in Q2 2024.
  • Lindbrook Capital opened 227 new positions and closed 115 in Q2 2024.
  • Lindbrook Capital's portfolio value fell 0.39% quarter-over-quarter to $1.06B.

Based on Lindbrook Capital's 13F filing for Q2 2024, filed 31 Jul 2024.